Cargando…
CYP17 promoter polymorphism and breast cancer risk in males and females in relation to BRCA2 status
A T–C polymorphism in the promoter region of the CYP17 gene has been associated with male and female breast cancer risk as well as early-onset familial breast cancer. The potential role of this polymorphism was investigated in relation to breast cancer risk in Icelandic male and female carriers and...
Autores principales: | Gudmundsdottir, K, Thorlacius, S, Jonasson, J G, Sigfusson, B F, Tryggvadottir, L, Eyfjord, J E |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2377070/ https://www.ncbi.nlm.nih.gov/pubmed/12644832 http://dx.doi.org/10.1038/sj.bjc.6600839 |
Ejemplares similares
-
BRCA2 mutation carriers, reproductive factors and breast cancer risk
por: Tryggvadottir, Laufey, et al.
Publicado: (2003) -
The GSTT1 genotype is associated with p53 mutation status of breast cancer tumours
por: Gudmundsdóttir, K, et al.
Publicado: (2000) -
Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype
por: Mitra, A, et al.
Publicado: (2008) -
BRCA1 Promoter Methylation Status in 1031 Primary Breast Cancers Predicts Favorable Outcomes Following Chemotherapy
por: Stefansson, Olafur A, et al.
Publicado: (2019) -
The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers
por: Sinilnikova, O M, et al.
Publicado: (2009)